SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Oncology Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Priston, M. J
Right arrow Articles by Sewell, G. J
Right arrow Search for Related Content
PubMed
Right arrow Articles by Priston, M. J
Right arrow Articles by Sewell, G. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Stability of three cytotoxic drug infusions in the Graseby 9000 ambulatory infusion pump

Melanie J Priston

Department of Pharmacy, Derriford Hospital and Postgraduate Medical School, University of Plymouth, Plymouth, UK

Graham J Sewell

Department of Pharmacy, Derriford Hospital and Postgraduate Medical School, University of Plymouth, Plymouth, UK

Objective. The purpose of this study was to deter mine the stability of three cytotoxic infusions in the Graseby 9000 ambulatory pump (Graseby Medical, Watford, UK) under both refrigerated storage and in-use conditions. The infusions studied were: (a) doxorubicin (2 mg/mL) plus vincristine (0.2 mg/mL) and (b) ifosfamide (20 mg/mL) plus mesna (20 mg/ mL) and etoposide (0.5 mg/mL). In each case, the diluent was water for injection.

Methods. Graseby 9000 medication cassettes, each containing one of three infusions studied, were incubated at either 8°C or 37°C to represent refriger ated storage or 'in-use' temperatures, respectively. Samples were withdrawn for chemical and physical analysis at various intervals. Chemical stability was determined using validated, stability-indicating high performance liquid chromatography methods. The assessment of physical stability included pH, appear ance, moisture loss from cassettes, subvisual particu late counts, and leaching of diethylhexylphthalate (DEHP) plasticiser from the medication cassettes.

Results. Both the doxorubicin plus vincristine and the ifosfamide plus mesna infusions were physi cally and chemically stable in Graseby 9000 medica tion cassettes for 14 days at 8°C and for 7 days at 37°C. The etoposide infusion caused significant leach ing of DEHP plasticiser from the Graseby cassette; in addition, one of the infusion cassettes stored at 8°C exhibited precipitation of etoposide by day 10.

Conclusion. Infusions of doxorubicin (2 mg/ mL) plus vincristine (0.2 mg/mL) and ifosfamide (20 mg/mL) plus mesna (20 mg/mL) demonstrated ac ceptable stability in the Graseby 9000 device under refrigerated storage and ambulatory infusion condi tions. Precipitation under refrigerated storage and significant leaching of DEHP would preclude the combination of etoposide infusion (0.5 mg/mL) and the Graseby 9000 pump for ambulatory administra tion.

Key Words: Doxorubicin • vincristine • ifosfamide; mesna • etoposide • stability.

Journal of Oncology Pharmacy Practice, Vol. 4, No. 3, 143-149 (1998)
DOI: 10.1177/107815529800400302


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement